Letter to the editorGain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival
References (7)
- et al.
Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1
Immunity
(2012) - et al.
STAT1-induced apoptosis is mediated by caspases 2, 3, and 7
J Biol Chem
(2004) - et al.
Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gamma
Leuk Res
(2002)
Cited by (72)
Type 1 diabetes and inborn errors of immunity: Complete strangers or 2 sides of the same coin?
2023, Journal of Allergy and Clinical ImmunologyAutoimmunity in primary immunodeficiency disorders
2019, The Autoimmune DiseasesBaricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)
2018, Journal of Allergy and Clinical Immunology
This work was supported by grant nos. AI061093, AI071087, AI082713, and AI095848 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (to E.M.), K12HD0141401-10 from the NIH/National Institute of Child Health and Human Development (to N.R.), and MO 2160/2-1 from the German Research Foundation (to H.M.) and the Division of Intramural Research, NIAID, NIH (to S.M.H. and J.D.M.).
All patient samples were collected in accordance with IRB-approved protocols.
Disclosure of potential conflict of interest: N. Romberg has received grants from the National Institutes of Health-National Institute of Child Health and Human Development. H. Morbach has received grants from the German Research Foundation. I. Kang has received grants from the National Institutes of Health. E. Meffre has received grants from the National Institutes of Health-National Institute of Allergy and Infectious Diseases and has received payment for lectures from Genentech. The rest of the authors declare that they have no relevant conflicts of interest.